10 April 2006 in Reproductive Biology and Endocrinology
The steroidogenic pathway within the ovary gives rise to progestins, androgens and oestrogens, all of which act via specific nuclear receptors to regulate reproductive function and maintain fertility. The role of progestins in follicular growth and development is limited, its action confined largely to ovulation, although direct effects on granulosa cell function have been reported. Consistent with these findings, progesterone receptor knockout mice are infertile because they cannot ovulate. Androgens have been shown to promote early follicular growth, but also to impede follicular development by stimulating atresia and apoptosis. The inability of androgens to transduce a signal in mice lacking androgen receptors culminates in reduced fertility. Oestrogens are known to exert effects on granulosa cell growth and differentiation in association with gonadotrophins. Studies with oestrogen receptor knockouts and oestrogen depleted mice have shown us that oestrogen is essential for folliculogenesis beyond the antral stage and is necessary to maintain the female phenotype of ovarian somatic cells. In summary, the action of steroids within the ovary is based on the developmental status of the follicle. In the absence of any single sex steroid, ovarian function and subsequently fertility, are compromised.
1 May 2002 in Molecular and Cellular Endocrinology
1 May 1999 in Molecular and Cellular Endocrinology
1 December 2001 in The Journal of Steroid Biochemistry and Molecular Biology
1 September 1989 in Molecular and Cellular Endocrinology
17 December 2009 in Journal of Endocrinology
This review examines the evidence for a central role of oestrogen receptor β (ERβ or ESR2 as listed in the MGI Database) in folliculogenesis and hence reproductive biology. Knockout mouse models have been a valuable resource in this respect. The ERβ-null mouse exhibits a granulosa cell phenotype associated with the partial arrest of folliculogenesis and ovulatory dysfunction. Phyto-oestrogens such as genistein, which preferentially activate ERβ, have been shown to alleviate the ovarian phenotype of the oestrogen-depleted aromatase knockout mouse. In normal adult mice, genistein has been shown to cause reproductive defectives following neonatal administration. Studies of ovarian cancer have also informed the literature. A decline in ERβ levels in epithelial ovarian cancers has been hypothesised to be associated with severity of disease and prognosis. Whereas the abundant expression of ERβ in granulosa cell tumours (GCT) of the ovary and evidence that ERβ signalling is transrepressed by the nuclear factor-κB pathway in GCT cell lines suggest a pathogenetic role for ERβ in GCT. In recent years, studies into the impact of environmental oestrogens (either in the form of pesticides or plastics) on reproductive function have shown that ERβ-selective toxins cause reproductive dysfunction and impair fertility. It remains to be established as to what genes are regulated by ERβ in the ovary. Finally, ERβ has been shown to be regulated by gonadotrophins, the pituitary hormones mediating ovarian function.